As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: February 24, 2011
by Alzheimer’s Reading Room:
New research finds that high cholesterol and high blood pressure not only put patients at risk for heart disease but are also risk factors for early memory loss and other cognitive problems.
In the study, participants underwent three cognitive tests during a 10-year period. The tests measured reasoning, memory, fluency, vocabulary, and rated each individual with a Framingham risk score. A Framinghman score, which is based on a government study of the same name, is used to predict one’s 10-year risk of a cardiovascular event and is based on age, sex, HDL cholesterol, total cholesterol, systolic blood pressure and whether or not a person smoked or had diabetes.
“We found that cardiovascular risk in middle age is related to lower overall cognitive function,” Sara Kaffashian, study co-author and doctoral student at INSERM, the French Institute of Health and Medical Research in Paris, told AOL Health.
Poor cognitive test scores, including memory problems, were linked with a 10 percent higher risk of cardiovascular problems and cognitive decline in both men and women.
“This is important from the prevention point of view because middle-aged individuals can improve their cardiovascular health in order to prevent or delay cognitive decline or dementia later in life,” says Kaffashian. “Our study builds on existing evidence for the importance of identifying and treating vascular risk factors particularly early in life.”
Kaffashian says vascular risk factors, such as high blood pressure, are currently the only treatable and preventable risk factors for memory decline and dementia.
“Therefore, active treatment of these risk factors through lifestyle modifications like smoking cessation and exercise, or medication, particularly early in life, may not only prevent stroke and heart disease but preserve cognitive function,” says Kaffashian.
“Evidence from clinical and pathological studies suggests that treating hypertension can decrease the risk of dementia,” she added.
Thirty-six million people worldwide suffer from Alzheimer’s disease and dementia. In Canada, 25,000 new cases are diagnosed each year. Those sobering numbers have researchers around the globe racing to come up with new ways to...
he Food and Drug Administration issued new guides on drug development for neurological disorders. This sets the stage for possible treatments for Alzheimer’s. The disease-oriented development guide documents will provide details on how researchers...
For young adults with autosomal dominant Alzheimer’s disease (AD), molecular markers can identify changes associated with the disease before clinical onset, according to a study published online Feb. 12 in JAMA Neurology. Yakeel T. Quiroz, Ph.D., from Massachusetts...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.